Search results
Apellis Surges And Breaks Out As FDA Mulls Its Eye-Disease Treatment
Investor's Business Daily· 2 years agoThe Food and Drug Administration accepted Apellis Pharmaceuticals' application for an eye-disease...
Private equity’s drive for eye care pushes up costs
Fortune via Yahoo Finance· 2 years agoAs private equity groups are swarming into aging America’s eye care, the consolidation is costing the U.S. health care system and patients more money.
Regeneron Stock Soars On Pair Of Successful Trials
Investor's Business Daily· 2 years agoRegeneron stock skyrocketed Thursday on news that an 8-milligram dose of an eye drug successfully treated patients with diabetic macular edema and wet...
Post Tua Tagovailoa, NFL needs to get its head out of the sand when it comes to concussions
The Gainesville Sun via Yahoo News· 2 years agoWarning: This column may not be up to its usual mediocre standards. On the way to my computer, I...
Letters: Understanding the importance of the 2020 election indictment against Donald Trump
The Florida Times-Union via Yahoo News· 8 months agoAs American citizens, we can participate in our democracy by being well-informed and open-minded...